Related Experiment Video
Updated: Jul 9, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Is kidney injury a reversible process?
Christos Chatziantoniou1, Jean-Claude Dussaule
1INSERM U702, Université Pierre et Marie Curie, Paris, France. christos.chatziantoniou@chusa.jussieu.fr
Purpose Of Review:
Recent evidence indicates that the progression of renal fibrosis is a reversible process in experimental models. This review summarizes the new insights concerning the mechanisms of progression and regression of renal disease and examines this novel evidence in the light of feasibility and transfer to human nephropathies.
Recent Findings:
Most of the studies investigated prevention rather than reversal of renal disease. Interesting results have been obtained using agents antagonizing the signaling pathway of transforming growth factor-beta, by blockers of the tyrosine kinase growth factor receptors and by kinin receptor activation.
Summary:
The future for therapy belongs to systems that mediate simultaneously proliferation, fibrosis and inflammation. Inhibitors of this kind of mediator will provide valuable assistance to 'classical' therapy with angiotensin II blockers, in order to achieve regression of renal fibrosis and reversal of renal failure.
Insights
Renal fibrosis progression is reversible. Novel therapies targeting simultaneous proliferation, fibrosis, and inflammation show promise for reversing kidney disease and renal failure.
Area of Science:
- Nephrology
- Renal Pathology
- Translational Medicine
Background:
- Renal fibrosis is a key factor in progressive kidney disease.
- Recent experimental evidence suggests fibrosis progression may be reversible.
- Understanding mechanisms of progression and regression is crucial for human nephropathies.
Purpose of the Study:
- To review new insights into the mechanisms of renal disease progression and regression.
- To examine the feasibility and transferability of novel findings to human kidney diseases.
- To explore therapeutic strategies for reversing renal fibrosis.
Main Methods:
- Review of recent experimental studies on renal fibrosis.
- Analysis of agents targeting specific molecular pathways.
- Evaluation of evidence for therapeutic interventions.
Main Results:
- Most studies focused on prevention rather than reversal of renal disease.
- Agents antagonizing transforming growth factor-beta signaling pathways showed promise.
- Blockers of tyrosine kinase growth factor receptors and kinin receptor activation yielded interesting results.
Conclusions:
- Therapeutic systems targeting simultaneous proliferation, fibrosis, and inflammation are the future.
- Inhibitors of these mediators can complement classical therapies like angiotensin II blockers.
- These approaches may achieve regression of renal fibrosis and reversal of renal failure.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

